Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01726257 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

A NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Endologix.

Completed
Registry status
NA
Development phase
333
Enrollment target
20
Study locations

NCT01726257: Completed NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Endologix.

NCT01726257 is a NA study of Abdominal Aortic Aneurysm (AAA) that has completed, run by Endologix. The registered enrollment target is 333 participants, above the 78-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (327% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01726257, a NA study of Abdominal Aortic Aneurysm (AAA), has completed, sponsored by Endologix.

COMPLETED
Registry status
NA
Development phase
333 participants
Enrollment target
20
Study locations

Study Summary

The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).

Primary Outcome

Major Adverse Events = all-cause death, bowel ischemia, myocardial infarction, paraplegia, renal failure, respiratory failure, stroke, and blood loss \>1,000cc

Interventions

  • DEVICE Nellix System

Study Locations (20)

Florida

  • Baptist Hospital of Miami - Miami
  • Sacred Heart - Pensacola

Massachusetts

  • St. Elizabeth's Medical Center - Brighton
  • Bay State Hospital - Springfield

Ohio

  • Cleveland Clinic - Cleveland
  • Ohio Health Research Institute - Columbus

Arizona

  • Tucson Medical Center - Tucson

California

  • VA San Diego - San Diego

Connecticut

  • Yale University - New Haven

Delaware

  • Christiana Care Hospital - Newark

District of Columbia

  • MedStar Health Research Institute - Washington D.C.

Trial Details

FieldValue
Enrollment Target 333 participants
Start Date 2013-12
Est. Completion 2022-12
Phase NA
Endologix

17 total trials

What the finished NCT01726257 record still lists

NCT01726257 is an interventional study that assigns participants to a tested intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap, above the 78-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (327% higher).

The record links to 1 condition, with Abdominal Aortic Aneurysm (AAA) appearing as the primary indexed condition, and to 1 intervention - of which Nellix System is the first listed.

NCT01726257 names 20 study sites across 17 states, led by Florida, Massachusetts, Ohio.

Frequently Asked Questions

What is clinical trial NCT01726257 about?

NCT01726257 is a clinical study titled "Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System". The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).

What is the current status of trial NCT01726257?

This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2013-12. Estimated completion is 2022-12.

What conditions does trial NCT01726257 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm (AAA).

What interventions are being tested in trial NCT01726257?

The interventions under investigation include: Nellix System (DEVICE).

Who is sponsoring clinical trial NCT01726257?

This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01726257 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Delaware, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysm (AAA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07395687 · 333 participants · Phase 2

    A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

  • NCT05131672 · 334 participants · NA

    Cast or Operation for Medial Epicondyle Fracture Treatment in Children

  • NCT05131685 · 334 participants · NA

    Distal Radius Interventions for Fracture Treatment

  • NCT05546931 · 334 participants · NA

    Mobile Health Program for Rural Hypertension

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01726257, the US trial registry maintained by the National Library of Medicine. NCT01726257 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.